AllianceBernstein’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-114,029
| Closed | -$1.68M | – | 3252 |
|
|
2025
Q3 | $1.68M | Buy |
114,029
+1,599
| +1% | +$16.3K | ﹤0.01% | 2108 |
|
|
2025
Q2 | $1.1M | Sell |
112,430
-41,396
| -27% | -$343K | ﹤0.01% | 2235 |
|
|
2025
Q1 | $1.12M | Sell |
153,826
-888,310
| -85% | -$7.77M | ﹤0.01% | 2187 |
|
|
2024
Q4 | $8.15M | Buy |
1,042,136
+455,074
| +78% | +$3.75M | ﹤0.01% | 1271 |
|
|
2024
Q3 | $4.34M | Buy |
587,062
+30,535
| +5% | +$257K | ﹤0.01% | 1575 |
|
|
2024
Q2 | $4.46M | Buy |
556,527
+325,520
| +141% | +$2.91M | ﹤0.01% | 1534 |
|
|
2024
Q1 | $2.69M | Sell |
231,007
-67,982
| -23% | -$753K | ﹤0.01% | 1762 |
|
|
2023
Q4 | $3.34M | Sell |
298,989
-44,685
| -13% | -$411K | ﹤0.01% | 1677 |
|
|
2023
Q3 | $5.31M | Buy |
343,674
+122,955
| +56% | +$2.06M | ﹤0.01% | 1392 |
|
|
2023
Q2 | $4.18M | Buy |
+220,719
| New | +$3.88M | ﹤0.01% | 1504 |
|
|
2023
Q1 | – | Sell |
-130,877
| Closed | -$1.67M | – | 3192 |
|
|
2022
Q4 | $1.67M | Buy |
+130,877
| New | +$1.18M | ﹤0.01% | 2026 |
|
|
2022
Q2 | – | Sell |
-12,700
| Closed | -$48K | – | 3302 |
|
|
2022
Q1 | $48K | Sell |
12,700
-1,300
| -9% | -$8.37K | ﹤0.01% | 3176 |
|
|
2021
Q4 | $183K | Hold |
14,000
| – | – | ﹤0.01% | 3095 |
|
|
2021
Q3 | $274K | Hold |
14,000
| – | – | ﹤0.01% | 2983 |
|
|
2021
Q2 | $262K | Buy |
14,000
+2,200
| +19% | +$49.1K | ﹤0.01% | 3063 |
|
|
2021
Q1 | $279K | Hold |
11,800
| – | – | ﹤0.01% | 2934 |
|
|
2020
Q4 | $288K | Buy |
11,800
+1,800
| +18% | +$46K | ﹤0.01% | 2876 |
|
|
2020
Q3 | $257K | Buy |
+10,000
| New | +$317K | ﹤0.01% | 2873 |
|
Other funds holding ETNB
AllianceBernstein's ETNB Position: Q4 2025 in Review
AllianceBernstein sold out of 89bio (ETNB) in Q4 2025, closing a stake of 114,029 shares — an estimated $1.68M sold.
AllianceBernstein first reported a position in ETNB in Q3 2020 and held it in 18 quarters. The position peaked at $8.15M in Q4 2024. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- AllianceBernstein reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- AllianceBernstein sold 114,029 89bio shares in Q4 2025, an estimated $1.68M.
- AllianceBernstein first reported a position in 89bio in Q3 2020 and held it in 18 quarters.
- AllianceBernstein's 89bio position peaked at $8.15M in Q4 2024.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on AllianceBernstein's 13F filing for Q4 2025, filed 17 Feb 2026.